Radium ra 223 dichloride
HealthData.Gov
Updated Oct 29, 2026
About this dataset
XOFIGO (radium Ra 223 dichloride) is an intravenous injection manufactured by Bayer HealthCare Pharmaceuticals Inc. It's a radioactive alpha-particle emitting agent used to treat prostate cancer that has spread to the bones. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Radium ra 223 dichloride
Access the FDA dataset for Radium ra 223 dichloride — ANDA 203971 submitted by Mylan Institutional LLC
Modified Jun 29, 2026